|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Zhang H, Yu P, et al: Effects of
matrine against the growth of human lung cancer and hepatoma cells
as well as lung cancer cell migration. Cytotechnology. 59:191–200.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Efferth T, Konkimalla VB, Wang YF, et al:
Prediction of broad spectrum resistance of tumors towards
anticancer drugs. Clin Cancer Res. 14:2405–2412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong J, Su SY, Wang MY and Zhan Z: Shenqi
fuzheng, an injection concocted from Chinese medicinal herbs,
combined with platinum-based chemotherapy for advanced non-small
cell lung cancer: a systematic review. J Exp Clin Cancer Res.
29:1372010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu XS, Jiang J, Jiao XY, Wu YE and Lin
JH: Matrine-induced apoptosis in leukemia U937 cells: involvement
of caspases activation and MAPK-independent pathways. Planta Med.
72:501–506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang HM and Li HQ: Anti-arrhythmic
effects of sophoridine and oxysophoridine. Zhongguo Yao Li Xue Bao.
20:517–520. 1999.
|
|
8
|
Ai J, Gao HH, He SZ, Wang L, Luo DL and
Yang BF: Effects of matrine, artemisinin, tetrandrine on cytosolic
[Ca2+]i in guinea pig ventricular myocytes. Acta
Pharmacol Sin. 22:512–515. 2001.PubMed/NCBI
|
|
9
|
Xu CQ, Dong DL, Du ZM, Chen QW, Gong DM
and Yang BF: Comparison of the anti-arrhythmic effects of matrine
and berbamine with amiodarone and RP58866. Yao Xue Xue Bao.
39:691–694. 2004.(In Chinese).
|
|
10
|
Hu ZL, Zhang JP, Yu XB, Lin W, Qian DH and
Wan MB: Effect of matrine on
lipopolysaccharides/D-galactosamine-induced hepatitis and tumor
necrosis factor release from macrophages in vitro. Zhongguo Yao Li
Xue Bao. 17:351–353. 1996.(In Chinese).
|
|
11
|
Liu J, Zhu M, Shi R and Yang M: Radix
Sophorae flavescentis for chronic hepatitis B: a systematic
review of randomized trials. Am J Chin Med. 31:337–354. 2003.
View Article : Google Scholar
|
|
12
|
Long Y, Lin XT, Zeng KL and Zhang L:
Efficacy of intramuscular matrine in the treatment of chronic
hepatitis B. Hepatobiliary Pancreat Dis Int. 3:69–72.
2004.PubMed/NCBI
|
|
13
|
Gao HY, Li GY, Lou MM, Li XY, Wei XY and
Wang JH: Hepato-protective effect of matrine salvianolic acid B
salt on carbon tetrachloride-induced hepatic fibrosis. J Inflamm.
9:162012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu JY, Hu JH, Zhu QG, Li FQ, Wang J and
Sun HJ: Effect of matrine on the expression of substance P receptor
and inflammatory cytokines production in human skin keratinocytes
and fibroblasts. Int Immunopharmacol. 7:816–823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Tan G, Jiang X, et al: Therapeutic
effects of matrine on primary and metastatic breast cancer. Am J
Chin Med. 38:1115–1130. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li LQ, Li XL, Wang L, et al: Matrine
inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7
cells. Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu T, Song Y, Chen H, Pan S and Sun X:
Matrine inhibits proliferation and induces apoptosis of pancreatic
cancer cells in vitro and in vivo. Biol Pharm Bull. 33:1740–1745.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo C, Zhong HJ, Zhu LM, et al: Inhibition
of matrine against gastric cancer cell line MNK45 growth and its
anti-tumor mechanism. Mol Biol Rep. 39:5459–5464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang CL, Liu SS, Ma YG, Liu YY, Xue YX and
Huang B: The influence of intraoperative pleural perfusion with
matrine-cisplatin or cisplatin on stromal cell-derived factor-1 in
non-small cell lung cancer patients with subclinical pleural
metastasis. Med Oncol. 29:574–581. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Li Y, Chen X, et al: Autophagy is
involved in anticancer effects of matrine on SGC-7901 human gastric
cancer cells. Oncol Rep. 26:115–124. 2011.PubMed/NCBI
|
|
21
|
Chui CH, Lau FY, Tang JC, et al:
Activities of fresh juice of Scutellaria barbata and warmed
water extract of Radix Sophorae Tonkinensis on
anti-proliferation and apoptosis of human cancer cell lines. Int J
Mol Med. 16:337–341. 2005.PubMed/NCBI
|
|
22
|
Hu MJ, Zeng H, Wu YL, et al: Synergistic
effects of matrine and 5-fluorouracil on tumor growth of the
implanted gastric cancer in nude mice. Chin J Dig Dis. 6:68–71.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo C, Zhu Y, Jiang T, et al: Matrine
induced gastric cancer MKN45 cells apoptosis via increasing
pro-apoptotic molecules of Bcl-2 family. Toxicology. 229:245–252.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma L, Wen S, Zhan Y, He Y, Liu X and Jiang
J: Anticancer effects of the Chinese medicine matrine on murine
hepatocellular carcinoma cells. Planta Med. 74:245–251. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu P, Liu Q, Liu K, Yagasaki K, Wu E and
Zhang G: Matrine suppresses breast cancer cell proliferation and
invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology.
59:219–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dai ZJ, Gao J, Ji ZZ, et al: Matrine
induces apoptosis in gastric carcinoma cells via alteration of
Fas/FasL and activation of caspase-3. J Ethnopharmacol. 123:91–96.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang S, Zhang Y, Zhuang Y, et al: Matrine
induces apoptosis in human acute myeloid leukemia cells via the
mitochondrial pathway and Akt inactivation. PLoS One. 7:e468532012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ
and Tao HM: Matrine induces caspase-dependent apoptosis in human
osteosarcoma cells in vitro and in vivo through the upregulation of
Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother
Pharmacol. 69:317–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang H, Hou C, Zhang S, et al: Matrine
upregulates the cell cycle protein E2F-1 and triggers apoptosis via
the mitochondrial pathway in K562 cells. Eur J Pharmacol.
559:98–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Niu H, Li H, Xu C and He P: Expression
profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung
cancer metastasis. Oncol Rep. 24:465–471. 2010.PubMed/NCBI
|
|
31
|
Niu H, Wang J, Li H and He P: Rapamycin
potentiates cytotoxicity by docetaxel possibly through
downregulation of survivin in lung cancer cells. J Exp Clin Cancer
Res. 30:282011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu J, Luo Q, Cheng P, Liu X, Bai M and Tu
M: The role of matrine and mitogen-ativated protein
kinase/extracellular signal-regulated kinase signal transduction in
the inhibition of the proliferation and migration of human
umbilical veins endothelial cells induced by lung cancer cells.
Zhongguo Fei Ai Za Zhi. 12:747–752. 2009.(In Chinese).
|
|
33
|
Chen Q, Liu L and Cao H: Effects of
matrine on the growth inhibition, c-myc and hTERT protein
expression in human adenocarcinoma lung cancer cell line A549.
Zhongguo Fei Ai Za Zhi. 11:559–562. 2008.(In Chinese).
|
|
34
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deveraux QL and Reed JC: IAP family
proteins - suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu S and Yang X: Cellular inhibitor of
apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer
Smac/DIABLO. J Biol Chem. 278:10055–10060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Altieri DC: The molecular basis and
potential role of survivin in cancer diagnosis and therapy. Trends
Mol Med. 7:542–547. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Marioni G, Bertolin A, Giacomelli L, et
al: Expression of the apoptosis inhibitor protein survivin in
primary laryngeal carcinoma and cervical lymph node metastasis.
Anticancer Res. 26:3813–3817. 2006.PubMed/NCBI
|
|
39
|
Osaka E, Suzuki T, Osaka S, et al:
Survivin as a prognostic factor for osteosarcoma patients. Acta
Histochem Cytochem. 39:95–100. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tran J, Rak J, Sheehan C, et al: Marked
induction of the IAP family antiapoptotic proteins survivin and
XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res
Commun. 264:781–788. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Harfouche R, Hassessian HM, Guo Y, et al:
Mechanisms which mediate the antiapoptotic effects of
angiopoietin-1 on endothelial cells. Microvasc Res. 64:135–147.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Als AB, Dyrskjot L, von der Maase H, et
al: Emmprin and survivin predict response and survival following
cisplatin-containing chemotherapy in patients with advanced bladder
cancer. Clin Cancer Res. 13:4407–4414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hinnis AR, Luckett JC and Walker RA:
Survivin is an independent predictor of short-term survival in poor
prognostic breast cancer patients. Br J Cancer. 96:639–645. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nakagawa Y, Abe S, Kurata M, et al: IAP
family protein expression correlates with poor outcome of multiple
myeloma patients in association with chemotherapy-induced
overexpression of multidrug resistance genes. Am J Hematol.
81:824–831. 2006. View Article : Google Scholar
|
|
45
|
Watanuki-Miyauchi R, Kojima Y, Tsurumi H,
et al: Expression of survivin and of antigen detected by a novel
monoclonal antibody, T332, is associated with outcome of diffuse
large B-cell lymphoma and its subtypes. Pathol Int. 55:324–330.
2005. View Article : Google Scholar
|
|
46
|
Schlette EJ, Medeiros LJ, Goy A, Lai R and
Rassidakis GZ: Survivin expression predicts poorer prognosis in
anaplastic large-cell lymphoma. J Clin Oncol. 22:1682–1688. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Adida C, Haioun C, Gaulard P, et al:
Prognostic significance of survivin expression in diffuse large
B-cell lymphomas. Blood. 96:1921–1925. 2000.PubMed/NCBI
|
|
48
|
Altieri DC: Survivin, cancer networks and
pathway-directed drug discovery. Nat Rev Cancer. 8:61–70. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Y, Zhang Z, Garbow JR, et al:
Chemoprevention of lung squamous cell carcinoma in mice by a
mixture of Chinese herbs. Cancer Prev Res. 2:634–640. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu Y, Xu Y, Ji W, et al: Anti-tumor
activities of matrine and oxymatrine: literature review. Tumour
Biol. Feb 14–2014.(Epub ahead of print).
|
|
51
|
Linglu D, Yuxiang L, Yaqiong X, et al:
Antinociceptive effect of matrine on vincristine-induced
neuropathic pain model in mice. Neurol Sci. Dec 14–2013.(Epub ahead
of print).
|
|
52
|
Haiyan W, Yuxiang L, Linglu D, et al:
Antinociceptive effects of matrine on neuropathic pain induced by
chronic constriction injury. Pharm Biol. 51:844–850. 2013.
View Article : Google Scholar : PubMed/NCBI
|
